BXC Stock Analysis: BlueLinx Holdings | NYSE
Industrial Distribution | NYSE, USA | Market Cap: 579m USD | 12M Return: 11.9% | US09624H2085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 12.5M
EPS Trend: -95.7%
Qual. Beats: 2
Rev. Trend: -68.7%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BlueLinx Holdings Inc. (NYSE: BXC) is a U.S.-based distributor of residential and commercial building products, headquartered in Marietta, Georgia, and founded in 2004. The company operates in two main product categories: specialty products (engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products) and structural products (lumber, plywood, oriented strand boards, rebars, remesh, and other wood products for structural support). BlueLinx serves a diverse customer base that includes national home centers, pro dealers, cooperatives, specialty distributors, regional and local dealers, and industrial manufacturers, distributing through warehouse sales, reload sales, and direct sales channels.
As a Trading Companies & Distributor within the Industrials sector, BlueLinx functions as an intermediary between manufacturers and end-users in the construction supply chain, adding value through inventory management, logistics, and tailored services rather than producing goods itself. Its performance is closely tied to U.S. housing starts and commercial construction activity, making it sensitive to interest rates, lumber price cycles, and broader residential construction trends.
- Housing starts decline pressures structural product volumes
- Lumber and OSB price volatility squeezes distribution margins
- Specialty product mix shift expands gross margin profile
| Net Income: -1.95m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 5.13 > 1.0 |
| NWC/Revenue: 26.46% < 20% (prev 29.24%; Δ -2.78% < -1%) |
| CFO/TA 0.05 > 3% & CFO 74.4m > Net Income -1.95m |
| Net Debt (727.6m) to EBITDA (75.0m): 9.70 < 3 |
| Current Ratio: 4.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (7.86m) vs 12m ago -1.48% < -2% |
| Gross Margin: 15.52% > 18% (prev 15.94%; Δ -0.42% > 0.5%) |
| Asset Turnover: 188.9% > 50% (prev 186.1%; Δ 2.79% > 0%) |
| Interest Coverage Ratio: 0.72 > 6 (EBIT TTM 31.0m / Interest Expense TTM 42.8m) |
| A: 0.50 (Total Current Assets 1.06b - Total Current Liabilities 264.9m) / Total Assets 1.60b |
| B: 0.33 (Retained Earnings 527.4m / Total Assets 1.60b) |
| C: 0.02 (EBIT TTM 31.0m / Avg Total Assets 1.59b) |
| D: 0.63 (Book Value of Equity 621.5m / Total Liabilities 982.1m) |
| Altman-Z'' = 5.13 = AAA |
| DSRI: 1.11 (Receivables 315.9m/278.7m, Revenue 3.01b/2.95b) |
| GMI: 1.03 (GM 15.94% / 15.52%) |
| AQI: 1.41 (AQ_t 0.13 / AQ_t-1 0.09) |
| SGI: 1.02 (Revenue 3.01b / 2.95b) |
| TATA: -0.05 (NI -1.95m - CFO 74.4m) / TA 1.60b) |
| Beneish M = -2.66 (Cap -4..+1) = A |
As of October 23, 2026, the stock is trading at USD 80.35 with a total of 189,939 shares traded. Over the past week, the price has changed by +9.65%, over one month by -2.59%, over three months by +38.75% and over the past year by +11.94%.
Current recommended Stop Loss: 76.10 (which is 5.3% or 1.2 ATR below the current price).
BlueLinx Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BXC.
- StrongBuy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 88.3 | 9.9% |
P/E Forward = 7.0323
P/S = 0.1923
P/B = 1.0094
P/EG = 2.1937
Revenue TTM = 3.01b USD
EBIT TTM = 31.0m USD
EBITDA TTM = 75.0m USD
Long Term Debt = 297.1m USD (from longTermDebt, last quarter)
Short Term Debt = 30.5m USD (from shortTermDebt, last quarter)
Debt = 1.05b USD (from shortLongTermDebtTotal, last quarter) + Leases 374.3m
Net Debt = 727.6m USD (calculated: Debt 1.05b - CCE 318.2m)
Enterprise Value = 1.31b USD (578.7m + Debt 1.05b - CCE 318.2m)
Interest Coverage Ratio = 0.72 (Ebit TTM 31.0m / Interest Expense TTM 42.8m)
EV/FCF = 22.51x (Enterprise Value 1.31b / FCF TTM 58.0m)
FCF Yield = 4.44% (FCF TTM 58.0m / Enterprise Value 1.31b)
FCF Margin = 1.93% (FCF TTM 58.0m / Revenue TTM 3.01b)
Net Margin = -0.06% (Net Income TTM -1.95m / Revenue TTM 3.01b)
Gross Margin = 15.52% ((Revenue TTM 3.01b - Cost of Revenue TTM 2.54b) / Revenue TTM)
Gross Margin QoQ = 17.16% (prev 15.92%)
Tobins Q-Ratio = 0.81 (Enterprise Value 1.31b / Total Assets 1.60b)
Interest Expense / Debt = 4.10% (Interest Expense 42.8m / Debt 1.05b)
Taxrate = 42.93% (4.82m / 11.2m)
NOPAT = 17.7m (EBIT 31.0m * (1 - 42.93%))
Current Ratio = 4.01 (Total Current Assets 1.06b / Total Current Liabilities 264.9m)
Debt / Equity = 1.68 (Debt 1.05b / totalStockholderEquity, last quarter 621.5m)
Debt / EBITDA = 9.70 (Net Debt 727.6m / EBITDA 75.0m)
Debt / FCF = 12.54 (Net Debt 727.6m / FCF TTM 58.0m)
Total Stockholder Equity = 619.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.12% (Net Income -1.95m / Total Assets 1.60b)
RoE = -0.31% (Net Income TTM -1.95m / Total Stockholder Equity 619.3m)
RoCE = 3.38% (EBIT 31.0m / Capital Employed (Equity 619.3m + L.T.Debt 297.1m))
RoIC = 1.45% (NOPAT 17.7m / Invested Capital 1.22b)
WACC = 5.47% (E(578.7m)/V(1.62b) * Re(11.14%) + D(1.05b)/V(1.62b) * Rd(4.10%) * (1-Tc(0.43)))
Discount Rate = 11.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.77 | Cagr: -4.62%
[DCF] Terminal Value 75.44% ; FCFF base≈58.0m ; Y1≈58.3m ; Y5≈61.7m
[DCF] Fair Price = 29.56 (EV 959.9m - Net Debt 727.6m = Equity 232.3m / Shares 7.86m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -95.65 | EPS CAGR: -66.22% | SUE: 0.96 | # QB: 2
Revenue Correlation: -68.74 | Revenue CAGR: -2.45% | SUE: 1.85 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.60 | Chg30d=+74.87% | Revisions=+40% | Analysts=3
EPS current Year (2026-12-31): EPS=1.89 | Chg30d=+108.48% | Revisions=+40% | GrowthEPS=+94.5% | GrowthRev=+5.6%
EPS next Year (2027-12-31): EPS=2.85 | Chg30d=+23.52% | Revisions=+40% | GrowthEPS=+51.2% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +67% (up=6, down=0)